vs
西方石油（OXY）与Surgery Partners, Inc.（SGRY）财务数据对比。点击上方公司名可切换其他公司
西方石油的季度营收约是Surgery Partners, Inc.的1.9倍（$1.7B vs $885.0M），西方石油净利率更高（6.9% vs -1.7%，领先8.6%），Surgery Partners, Inc.同比增速更快（2.4% vs -75.8%），西方石油自由现金流更多（$1.9B vs $90.6M），过去两年Surgery Partners, Inc.的营收复合增速更高（11.1% vs -50.4%）
西方石油是一家美国能源企业，核心业务覆盖美国及中东地区的油气勘探，以及美国、加拿大、智利的石化产品制造。公司注册于特拉华州，总部位于休斯顿，2021年分别位列财富500强第183位、福布斯全球企业2000强第670位。
Surgery Partners, Inc.（NASDAQ代码：SGRY）旗下的United Surgical Partners International（USPI）是美国领先的日间手术护理服务商，总部位于得克萨斯州达拉斯，由唐·斯廷于1998年创立，专注于为患者提供便捷、高效的门诊外科医疗服务，运营多家合规手术中心，覆盖美国多地医疗需求场景。
OXY vs SGRY — 直观对比
营收规模更大
OXY
是对方的1.9倍
$885.0M
营收增速更快
SGRY
高出78.2%
-75.8%
净利率更高
OXY
高出8.6%
-1.7%
自由现金流更多
OXY
多$1.8B
$90.6M
两年增速更快
SGRY
近两年复合增速
-50.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $885.0M |
| 净利润 | $114.0M | $-15.0M |
| 毛利率 | — | — |
| 营业利润率 | -6.5% | 12.5% |
| 净利率 | 6.9% | -1.7% |
| 营收同比 | -75.8% | 2.4% |
| 净利润同比 | 195.0% | 86.2% |
| 每股收益（稀释后） | $-0.07 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OXYSGRY
| Q4 25 | $1.7B | $885.0M | ||
| Q3 25 | $6.7B | $821.5M | ||
| Q2 25 | $6.3B | $826.2M | ||
| Q1 25 | $6.9B | $776.0M | ||
| Q4 24 | $6.9B | $864.4M | ||
| Q3 24 | $7.0B | $770.4M | ||
| Q2 24 | $6.8B | $762.1M | ||
| Q1 24 | $6.7B | $717.4M |
净利润OXYSGRY
| Q4 25 | $114.0M | $-15.0M | ||
| Q3 25 | $842.0M | $-22.7M | ||
| Q2 25 | $468.0M | $-2.5M | ||
| Q1 25 | $945.0M | $-37.7M | ||
| Q4 24 | $-120.0M | $-108.5M | ||
| Q3 24 | $1.1B | $-31.7M | ||
| Q2 24 | $1.2B | $-15.5M | ||
| Q1 24 | $888.0M | $-12.4M |
毛利率OXYSGRY
| Q4 25 | — | — | ||
| Q3 25 | 87.8% | — | ||
| Q2 25 | 86.6% | — | ||
| Q1 25 | 88.4% | — | ||
| Q4 24 | 89.0% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 87.9% | — | ||
| Q1 24 | 89.0% | — |
营业利润率OXYSGRY
| Q4 25 | -6.5% | 12.5% | ||
| Q3 25 | 17.4% | 12.9% | ||
| Q2 25 | 11.7% | 13.5% | ||
| Q1 25 | 19.3% | 8.0% | ||
| Q4 24 | -2.5% | 14.7% | ||
| Q3 24 | 22.7% | 7.9% | ||
| Q2 24 | 24.0% | 11.1% | ||
| Q1 24 | 15.0% | 10.6% |
净利率OXYSGRY
| Q4 25 | 6.9% | -1.7% | ||
| Q3 25 | 12.6% | -2.8% | ||
| Q2 25 | 7.4% | -0.3% | ||
| Q1 25 | 13.7% | -4.9% | ||
| Q4 24 | -1.7% | -12.6% | ||
| Q3 24 | 16.2% | -4.1% | ||
| Q2 24 | 17.2% | -2.0% | ||
| Q1 24 | 13.2% | -1.7% |
每股收益（稀释后）OXYSGRY
| Q4 25 | $-0.07 | $-0.11 | ||
| Q3 25 | $0.65 | $-0.18 | ||
| Q2 25 | $0.26 | $-0.02 | ||
| Q1 25 | $0.77 | $-0.30 | ||
| Q4 24 | $-0.32 | $-0.86 | ||
| Q3 24 | $0.98 | $-0.25 | ||
| Q2 24 | $1.03 | $-0.12 | ||
| Q1 24 | $0.75 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0B | $239.9M |
| 总债务越低越好 | $20.6B | $3.6B |
| 股东权益账面价值 | $36.0B | $1.7B |
| 总资产 | $84.2B | $8.1B |
| 负债/权益比越低杠杆越低 | 0.57× | 2.10× |
8季度趋势，按日历期对齐
现金及短期投资OXYSGRY
| Q4 25 | $2.0B | $239.9M | ||
| Q3 25 | $2.2B | $203.4M | ||
| Q2 25 | $2.3B | $250.1M | ||
| Q1 25 | $2.6B | $229.3M | ||
| Q4 24 | $2.1B | $269.5M | ||
| Q3 24 | $1.8B | $221.8M | ||
| Q2 24 | $1.8B | $213.5M | ||
| Q1 24 | $1.3B | $185.2M |
总债务OXYSGRY
| Q4 25 | $20.6B | $3.6B | ||
| Q3 25 | $20.8B | $3.5B | ||
| Q2 25 | $23.3B | $3.5B | ||
| Q1 25 | $24.0B | $3.4B | ||
| Q4 24 | $25.0B | $3.3B | ||
| Q3 24 | $25.5B | $3.1B | ||
| Q2 24 | $18.4B | $3.0B | ||
| Q1 24 | $18.5B | $2.8B |
股东权益OXYSGRY
| Q4 25 | $36.0B | $1.7B | ||
| Q3 25 | $36.3B | $1.7B | ||
| Q2 25 | $35.7B | $1.7B | ||
| Q1 25 | $34.7B | $1.7B | ||
| Q4 24 | $34.2B | $1.8B | ||
| Q3 24 | $34.7B | $1.9B | ||
| Q2 24 | $32.1B | $2.0B | ||
| Q1 24 | $30.8B | $2.0B |
总资产OXYSGRY
| Q4 25 | $84.2B | $8.1B | ||
| Q3 25 | $83.5B | $7.9B | ||
| Q2 25 | $84.4B | $8.0B | ||
| Q1 25 | $85.0B | $7.9B | ||
| Q4 24 | $85.4B | $7.9B | ||
| Q3 24 | $85.8B | $7.5B | ||
| Q2 24 | $76.2B | $7.5B | ||
| Q1 24 | $74.3B | $7.0B |
负债/权益比OXYSGRY
| Q4 25 | 0.57× | 2.10× | ||
| Q3 25 | 0.57× | 2.00× | ||
| Q2 25 | 0.65× | 1.98× | ||
| Q1 25 | 0.69× | 1.98× | ||
| Q4 24 | 0.73× | 1.83× | ||
| Q3 24 | 0.73× | 1.63× | ||
| Q2 24 | 0.57× | 1.56× | ||
| Q1 24 | 0.60× | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.6B | $103.4M |
| 自由现金流经营现金流 - 资本支出 | $1.9B | $90.6M |
| 自由现金流率自由现金流/营收 | 113.4% | 10.2% |
| 资本支出强度资本支出/营收 | 45.4% | 1.4% |
| 现金转化率经营现金流/净利润 | 23.11× | — |
| 过去12个月自由现金流最近4个季度 | $4.1B | $195.6M |
8季度趋势，按日历期对齐
经营现金流OXYSGRY
| Q4 25 | $2.6B | $103.4M | ||
| Q3 25 | $2.8B | $83.6M | ||
| Q2 25 | $3.0B | $81.3M | ||
| Q1 25 | $2.1B | $6.0M | ||
| Q4 24 | $3.4B | $111.4M | ||
| Q3 24 | $3.7B | $65.2M | ||
| Q2 24 | $2.4B | $82.8M | ||
| Q1 24 | $2.0B | $40.7M |
自由现金流OXYSGRY
| Q4 25 | $1.9B | $90.6M | ||
| Q3 25 | $1.0B | $63.8M | ||
| Q2 25 | $962.0M | $57.9M | ||
| Q1 25 | $240.0M | $-16.7M | ||
| Q4 24 | $1.6B | $89.1M | ||
| Q3 24 | $2.0B | $45.0M | ||
| Q2 24 | $623.0M | $55.9M | ||
| Q1 24 | $224.0M | $19.7M |
自由现金流率OXYSGRY
| Q4 25 | 113.4% | 10.2% | ||
| Q3 25 | 15.3% | 7.8% | ||
| Q2 25 | 15.2% | 7.0% | ||
| Q1 25 | 3.5% | -2.2% | ||
| Q4 24 | 23.0% | 10.3% | ||
| Q3 24 | 28.5% | 5.8% | ||
| Q2 24 | 9.2% | 7.3% | ||
| Q1 24 | 3.3% | 2.7% |
资本支出强度OXYSGRY
| Q4 25 | 45.4% | 1.4% | ||
| Q3 25 | 26.5% | 2.4% | ||
| Q2 25 | 31.6% | 2.8% | ||
| Q1 25 | 27.6% | 2.9% | ||
| Q4 24 | 26.0% | 2.6% | ||
| Q3 24 | 24.0% | 2.6% | ||
| Q2 24 | 26.0% | 3.5% | ||
| Q1 24 | 26.5% | 2.9% |
现金转化率OXYSGRY
| Q4 25 | 23.11× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | 6.32× | — | ||
| Q1 25 | 2.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.23× | — | ||
| Q2 24 | 2.05× | — | ||
| Q1 24 | 2.26× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OXY
暂无分部数据
SGRY
| Private Insurance | $460.5M | 52% |
| Government Revenue | $368.6M | 42% |
| Other | $19.8M | 2% |
| Self Pay Revenue | $19.6M | 2% |
| Other Patient Service Revenue Sources | $16.5M | 2% |
